1Petersen PJ,Brad ford PA, Weiss WJ,et al. In vitro and in vfi)o activ- ities of tigecycline ( GAR-936 ), daptomycin, and comparative antimi- crobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant grampositive pathogens [ J ]. Antimicrob Agents Chemother ,2002,46 ( 8 ) : 2595-2601. 被引量：1
2Zhanel GG, Karlowsky JA, Rubinstein E, et al. Tigecycline : a novel glycylcycline antibiotic[ J]. Expert Rev Anti Infect Ther,2006, 4( 1 ) : 9-25. 被引量：1
3Guay DR. Oritavancin and tigeeyeline: investigationalantimierobials for multidrug-resistant bacteria[ J]. Pharmacotherapy, 2004,24 ( 1 ) : 58-68. 被引量：1
4Tanaseanu C, Milutinovic S, Calistru PI, et al. Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia [J]. BMC Pulm Med ,2009 ,9 :44. 被引量：1
5ZHAO Yu-zheng, L Pei-de(赵玉珍, 吕佩德). Chinese Journal of Analysis Laboratory(分析试验室), 1997, 16(6): 25. 被引量：2
6SUN Zhen-hua, LI Bing, SUN Da-hai, ZHANG Zhi-gang, YING Hai, GU Sheng, WANG Xiao-ru(孙振华, 李冰, 孙大海, 张志刚, 应海, 谷胜, 王小如). Spectroscopy and Spectral Analysis(光谱学与光谱分析), 2001, 21(1): 57. 被引量：2
7WANG Chun-mei, ZHU Lian-qing, ZHANG Shu-zheng, L Qiong, WANG Jin-gang(王春梅, 褚连青, 张淑珍, 吕琼, 王金钢). Chinese Journal of Rare Metal(稀有金属), 1999, (2): 159. 被引量：2
8LIFei(李飞).Chinese Journal of Rare Earth(稀土),1999,20(2):63-63. 被引量：2
